LOKELMA is a Oral Powder, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Sodium Zirconium Cyclosilicate.
Product ID | 0310-1105_2ba30e76-7e86-4c7d-a1ea-1ed04f7984e5 |
NDC | 0310-1105 |
Product Type | Human Prescription Drug |
Proprietary Name | LOKELMA |
Generic Name | Sodium Zirconium Cyclosilicate |
Dosage Form | Powder, For Suspension |
Route of Administration | ORAL |
Marketing Start Date | 2018-09-04 |
Marketing Category | NDA / NDA |
Application Number | NDA207078 |
Labeler Name | AstraZeneca Pharmaceuticals LP |
Substance Name | SODIUM ZIRCONIUM CYCLOSILICATE |
Active Ingredient Strength | 5 g/5g |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2018-09-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA207078 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-09-04 |
Marketing Category | NDA |
Application Number | NDA207078 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-09-04 |
Marketing Category | NDA |
Application Number | NDA207078 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-01-02 |
Ingredient | Strength |
---|---|
SODIUM ZIRCONIUM CYCLOSILICATE | 5 g/5g |
SPL SET ID: | 90bf8e28-748d-4e4b-a19f-9cf483370eff |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0310-1105 | LOKELMA | sodium zirconium cyclosilicate |
0310-1110 | LOKELMA | sodium zirconium cyclosilicate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LOKELMA 87936350 5723751 Live/Registered |
ZS Pharma, Inc. 2018-05-25 |
LOKELMA 87604023 5728779 Live/Registered |
ZS Pharma, Inc. 2017-09-11 |
LOKELMA 86240215 not registered Dead/Abandoned |
ZS PHARMA, INC. 2014-04-02 |